Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences
Jazz Pharmaceuticals (Nasdaq: JAZZ) has announced its participation in two major investor conferences in June 2025. The company will join the Jefferies Global Healthcare Conference on June 5, with a fireside chat scheduled for 6:55 a.m. PDT, and the Goldman Sachs 46th Annual Global Healthcare Conference on June 11, featuring a fireside chat at 7:00 a.m. PDT.
Audio webcasts of both presentations will be accessible through Jazz Pharmaceuticals' investor relations website, with recordings available for 30 days after the events. Jazz Pharmaceuticals is a global biopharma company focused on developing life-changing medicines for serious diseases, with a portfolio spanning sleep disorders, epilepsy, and cancer treatments.
Jazz Pharmaceuticals (Nasdaq: JAZZ) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel giugno 2025. La società parteciperà alla Jefferies Global Healthcare Conference il 5 giugno, con una sessione informale prevista per le 6:55 a.m. PDT, e alla Goldman Sachs 46th Annual Global Healthcare Conference l'11 giugno, con una sessione informale alle 7:00 a.m. PDT.
Le trasmissioni audio in streaming di entrambe le presentazioni saranno disponibili sul sito web delle relazioni con gli investitori di Jazz Pharmaceuticals, con le registrazioni accessibili per 30 giorni dopo gli eventi. Jazz Pharmaceuticals è un'azienda biofarmaceutica globale focalizzata sullo sviluppo di farmaci innovativi per malattie gravi, con un portafoglio che comprende disturbi del sonno, epilessia e trattamenti oncologici.
Jazz Pharmaceuticals (Nasdaq: JAZZ) ha anunciado su participación en dos importantes conferencias para inversores en junio de 2025. La compañía asistirá a la Jefferies Global Healthcare Conference el 5 de junio, con una charla informal programada para las 6:55 a.m. PDT, y a la Goldman Sachs 46th Annual Global Healthcare Conference el 11 de junio, con una charla informal a las 7:00 a.m. PDT.
Las transmisiones de audio en vivo de ambas presentaciones estarán disponibles a través del sitio web de relaciones con inversores de Jazz Pharmaceuticals, con grabaciones accesibles durante 30 días después de los eventos. Jazz Pharmaceuticals es una compañía biofarmacéutica global enfocada en desarrollar medicamentos innovadores para enfermedades graves, con un portafolio que abarca trastornos del sueño, epilepsia y tratamientos contra el cáncer.
Jazz Pharmaceuticals (나스닥: JAZZ)는 2025년 6월 두 개의 주요 투자자 컨퍼런스에 참여할 예정임을 발표했습니다. 회사는 6월 5일 Jefferies Global Healthcare Conference에 참석하며, 오전 6시 55분(PDT)에 파이어사이드 챗이 예정되어 있고, 6월 11일에는 Goldman Sachs 46th Annual Global Healthcare Conference에 참석하여 오전 7시(PDT)에 파이어사이드 챗이 진행됩니다.
두 발표 모두 Jazz Pharmaceuticals 투자자 관계 웹사이트를 통해 오디오 웹캐스트로 제공되며, 이벤트 종료 후 30일간 녹화본을 시청할 수 있습니다. Jazz Pharmaceuticals는 수면 장애, 간질, 암 치료제를 포함한 심각한 질환을 위한 혁신적인 의약품 개발에 주력하는 글로벌 바이오제약 회사입니다.
Jazz Pharmaceuticals (Nasdaq : JAZZ) a annoncé sa participation à deux grandes conférences pour investisseurs en juin 2025. La société prendra part à la Jefferies Global Healthcare Conference le 5 juin, avec une discussion informelle prévue à 6h55 PDT, et à la Goldman Sachs 46th Annual Global Healthcare Conference le 11 juin, avec une discussion informelle à 7h00 PDT.
Les webcasts audio des deux présentations seront accessibles via le site web des relations investisseurs de Jazz Pharmaceuticals, avec les enregistrements disponibles pendant 30 jours après les événements. Jazz Pharmaceuticals est une entreprise biopharmaceutique mondiale spécialisée dans le développement de médicaments révolutionnaires pour les maladies graves, avec un portefeuille couvrant les troubles du sommeil, l'épilepsie et les traitements contre le cancer.
Jazz Pharmaceuticals (Nasdaq: JAZZ) hat seine Teilnahme an zwei bedeutenden Investorenkonferenzen im Juni 2025 bekanntgegeben. Das Unternehmen wird am 5. Juni an der Jefferies Global Healthcare Conference teilnehmen, mit einem Fireside-Chat um 6:55 Uhr PDT, und am 11. Juni an der Goldman Sachs 46th Annual Global Healthcare Conference, mit einem Fireside-Chat um 7:00 Uhr PDT.
Audio-Webcasts beider Präsentationen sind über die Investor-Relations-Website von Jazz Pharmaceuticals zugänglich, wobei die Aufzeichnungen 30 Tage nach den Veranstaltungen verfügbar sind. Jazz Pharmaceuticals ist ein globales Biopharma-Unternehmen, das sich auf die Entwicklung lebensverändernder Medikamente für schwere Krankheiten spezialisiert hat, mit einem Portfolio, das Schlafstörungen, Epilepsie und Krebstherapien umfasst.
- None.
- None.
Jefferies Global Healthcare Conference on Thursday, June 5, 2025
- Fireside chat at 6:55 a.m. PDT / 9:55 a.m. EDT / 2:55 p.m. IST
Goldman Sachs 46th Annual Global Healthcare Conference on Wednesday, June 11, 2025
- Fireside chat at 7:00 a.m. PDT / 10:00 a.m. EDT / 3:00 p.m. IST
Audio webcasts of the presentations will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcasts will be archived on the website for 30 days.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in
Contacts:
Investors:
Jeff Macdonald
Executive Director, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-upcoming-june-investor-conferences-302462449.html
SOURCE Jazz Pharmaceuticals plc
FAQ
When is Jazz Pharmaceuticals (JAZZ) presenting at the Jefferies Global Healthcare Conference 2025?
What time is Jazz Pharmaceuticals' presentation at the Goldman Sachs Healthcare Conference 2025?
How long will Jazz Pharmaceuticals' (JAZZ) conference webcasts be available for replay?
What are the main therapeutic areas of focus for Jazz Pharmaceuticals (JAZZ)?
